Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mindray Medical International Ltd Reaffirms FY 2013 Revenue Guidance; Issues FY 2013 Net Income Guidance Above Analysts' Estimates; Declares Cash Dividend


Monday, 25 Feb 2013 05:00pm EST 

Mindray Medical International Ltd announced that for fiscal 2013, it expects net revenues to grow at least 17% over its fiscal 2012 net revenues, non-GAAP net income to grow at least 15% over its non-GAAP net income for fiscal 2012. The Company reported revenue of $1.060 billion and net income of $180.2 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report net income of $197 million for fiscal 2013. The Company's board of directors also has declared a cash dividend on its ordinary shares of $0.50 per share, based on the company's net income for the full year 2012. The cash dividend will be payable on or around April 8, 2013, to shareholders of record as of March 8, 2013. The company has approximately 119 million outstanding ordinary shares as of January 31, 2013. Declared dividend of $0.50 per share, representing a 25% increase from 2011. 

Company Quote

26.91
-0.1 -0.37%
19 Dec 2014